Fortrea to sell endpoint clinical and patient ... a provider of services for clinical research organizations (CROs) that is based in Durham, North Carolina. The deal closed in June.

Oren Cohen, president of clinical pharmacology of clinical research organisation (CRO) Fortrea says that it is all good and well asking sponsors to improve the diversity of patients, but sponsors ...

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the ...

Called Evinova, the new unit has emerged with alliances already in place with contract research organisations Parexel and Fortrea ... design and planning of new clinical trials, drawing on ...

Fortrea, Lonza, Medpace, Parexel International Corp, Samsung Biologics, Syneos Health, Thermo Fisher Scientific, and WuXi AppTec dominate the market. These companies offer end-to-end solutions, from ...

Fortrea operates in the U.S. Life Science Tools & Diagnostics sector, offering a range of services to support drug development and clinical trials. With a global presence, the company has positioned ...

DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth ...